Back to Search Start Over

Adjuvant Chemotherapy for ER+ Breast Cancer: A Sea Change is Underway.

Authors :
Poorvu, Philip D.
Winer, Eric P.
Source :
JNCI: Journal of the National Cancer Institute. May2018, Vol. 110 Issue 5, p443-445. 3p.
Publication Year :
2018

Abstract

The article focuses on breast cancer treatment. Topics discussed include use of epidermal growth factor receptor 2 (HER2)–targeted therapies for treating the same; advantages of chemotherapy for treating breast cancer; and risk of developing recurrent breast cancer, and use of complex randomized trial for the same.

Subjects

Subjects :
*BREAST cancer treatment
*BREAST cancer patients
*EPIDERMAL growth factor receptors
*CANCER chemotherapy
*RANDOMIZED controlled trials

Details

Language :
English
ISSN :
00278874
Volume :
110
Issue :
5
Database :
Academic Search Index
Journal :
JNCI: Journal of the National Cancer Institute
Publication Type :
Academic Journal
Accession number :
129563906
Full Text :
https://doi.org/10.1093/jnci/djx264
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details